Other Income & Expense
Change in AP
Vertex Pharmaceuticals Change in AP decreased by 7.0% to $35.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.9%, from $26.20M to $35.60M. Over 4 years (FY 2021 to FY 2025), Change in AP shows an upward trend with a 3.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase suggests the company is effectively using supplier credit to manage cash flow, while a decrease indicates faster payment of liabilities.
Detailed definition
Represents the net change in obligations to suppliers for goods and services received but not yet paid for. It is a crit...
Peer comparison
Standard working capital metric; compared against days payable outstanding (DPO) at peer firms.
Metric ID:
ms_change_in_accounts_payableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$13.70M | $2.30M | $53.90M | -$14.50M | $45.30M | -$69.90M | $159.90M | $12.18M | $12.18M | $12.18M | $12.18M | $100.00K | -$25.10M | $66.10M | $8.40M | $26.20M | $7.60M | -$35.30M | $38.30M | $35.60M |
| QoQ Change | — | +116.8% | >999% | -126.9% | +412.4% | -254.3% | +328.8% | -92.4% | +0.0% | +0.0% | +0.0% | -99.2% | <-999% | +363.3% | -87.3% | +211.9% | -71.0% | -564.5% | +208.5% | -7.0% |
| YoY Change | — | — | — | — | +430.7% | <-999% | +196.7% | +184.0% | -73.1% | +117.4% | -92.4% | -99.2% | -306.2% | +442.9% | -31.0% | >999% | +130.3% | -153.4% | +356.0% | +35.9% |
Range-$69.90M – $159.90M
CAGR+22.3%
Avg YoY Growth>999%
Median YoY Growth+76.6%
Change in AP at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's change in ap?
- Vertex Pharmaceuticals (VRTX) reported change in ap of $35.60M in Q1 2026.
- How has Vertex Pharmaceuticals's change in ap changed year-over-year?
- Vertex Pharmaceuticals's change in ap increased by 35.9% year-over-year, from $26.20M to $35.60M.
- What is the long-term trend for Vertex Pharmaceuticals's change in ap?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's change in ap has grown at a 3.6% compound annual growth rate (CAGR), from $31.90M to $36.80M.
- What does change in ap mean?
- The change in money the company owes to its suppliers.